Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nesiritide in infants following cardiopulmonary bypass
NCT00281671Phase 2Terminated
- Sponsor
- Boston Children's Hospital
- Start
- Apr 2006
- Primary completion
- Oct 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of nesiritide in congenital heart defects (CHD), sponsored by Boston Children's Hospital. Started Apr 2006; status: terminated.
02
Drugs
nesiritide
03
Conditions
congenital heart defects (CHD)
Beyond the preview
Go deeper on NCT00281671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00281671.